SaiLong Pharmaceutical plans to apply for a comprehensive credit line of 10 million from the Zhuhai branch of INDUSTRIAL BANK

On September 19, 2025, SaiLong Pharmaceutical Group Co., Ltd. held the 15th meeting of the fourth board of directors, reviewing and approving the proposal on the company's application for credit limits from banks. To meet production and operational needs and business development, the company intends to apply for a comprehensive credit limit of 10 million yuan from the Zhuhai branch of INDUSTRIAL BANK, with a term of 1 year, for purposes including working capital loans. The actual financing amount will depend on operational needs and will be subject to the actual signed contract, with the limit being reusable. The board of directors authorized the management to decide on related matters and sign documents within the limit, with the company bearing the responsibility. This application is within the scope of the board's review and does not require shareholder meeting approval, with the credit limit starting from the date of board approval